Patents by Inventor Wangyang MIN

Wangyang MIN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220289740
    Abstract: The present invention provides an RET selective inhibitor and preparation method and use thereof; the present invention provides a compound of formula (1) and a pharmaceutically accepted salt, solvate, polymorph, or tautomer thereof, a composition comprising these compounds, and use of these compounds in the treatment of diseases related to RET.
    Type: Application
    Filed: July 10, 2020
    Publication date: September 15, 2022
    Inventors: Zhihua LIU, Dechuang YUAN, Kuncheng CHEN, Baokun YUAN, Ren REN, Wangyang MIN, Xijie LIU, Kai ZHANG, Yongliang SUN, Chang LU, Yinghui SUN
  • Publication number: 20220185811
    Abstract: The invention relates to an FGFR4 kinase inhibitor, and the preparation method and use thereof. The invention relates to a compound of Formula I, or a pharmaceutically acceptable salt, solvate, polymorph or tautomer thereof, and use thereof in the manufacture of a medicament for the treatment of an FGFR4 mediated disease.
    Type: Application
    Filed: March 6, 2020
    Publication date: June 16, 2022
    Inventors: Jinghan WANG, Jinsuo YAO, Xiaowei DUAN, Baokun YUAN, Xijie LIU, Nan JIAO, Wangyang MIN, Ying SUN, Chang LU, Yinghui SUN, Jiuqing ZHANG, Yeling JI, Deng HOU